265 related articles for article (PubMed ID: 31685971)
1. Treatment choices for newly diagnosed primary open angle and ocular hypertension patients.
Garg A; Gazzard G
Eye (Lond); 2020 Jan; 34(1):60-71. PubMed ID: 31685971
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Goldmann and ORA tonometers in newly diagnosed, untreated, POAG and OHT eyes.
Sánchez-Barahona C; Bolívar G; Teus MA
Arch Soc Esp Oftalmol (Engl Ed); 2023 Sep; 98(9):528-532. PubMed ID: 37595792
[TBL] [Abstract][Full Text] [Related]
3. [Glaucoma and ocular hypertension: the importance of intraocular pressure in treatment decisions in France].
Bron A; Nordmann JP; Baudouin C; Rouland JF; Kadi A; Sartral M
J Fr Ophtalmol; 2003 Nov; 26(9):895-903. PubMed ID: 14631273
[TBL] [Abstract][Full Text] [Related]
4. Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort.
Yang Y; Zhang X; Chen Z; Wei Y; Ye Q; Fan Y; Nathwani N; Gazzard G; Yu M;
Br J Ophthalmol; 2023 Jun; 107(6):823-827. PubMed ID: 35086806
[TBL] [Abstract][Full Text] [Related]
5. Latanoprost treatment differentially affects intraocular pressure readings obtained with three different tonometers.
Sánchez-Barahona C; Bolívar G; Katsanos A; Teus MA
Acta Ophthalmol; 2019 Dec; 97(8):e1112-e1115. PubMed ID: 31184426
[TBL] [Abstract][Full Text] [Related]
6. Intraocular pressure changes following topical ocular hypotensive medications washout.
Ho H; Daas A; Ho J; Alaghband P; Galvis EA; de Antonio Ramirez A; Grassi P; Lim R; Lim KS
Br J Ophthalmol; 2021 Feb; 105(2):205-209. PubMed ID: 32277009
[TBL] [Abstract][Full Text] [Related]
7. Intravenous Hypertonic Saline to Lower Intraocular Pressure in Ocular Hypertension and Primary Open-angle and Exfoliation Glaucoma.
Inborr PK; Harju M; Kivelä TT
J Glaucoma; 2018 Jul; 27(7):638-642. PubMed ID: 29750719
[TBL] [Abstract][Full Text] [Related]
8. Ocular response analyser to assess hysteresis and corneal resistance factor in low tension, open angle glaucoma and ocular hypertension.
Shah S; Laiquzzaman M; Mantry S; Cunliffe I
Clin Exp Ophthalmol; 2008 Aug; 36(6):508-13. PubMed ID: 18954311
[TBL] [Abstract][Full Text] [Related]
9. Corneal biomechanics and biomechanically corrected intraocular pressure in primary open-angle glaucoma, ocular hypertension and controls.
Vinciguerra R; Rehman S; Vallabh NA; Batterbury M; Czanner G; Choudhary A; Cheeseman R; Elsheikh A; Willoughby CE
Br J Ophthalmol; 2020 Jan; 104(1):121-126. PubMed ID: 30923134
[TBL] [Abstract][Full Text] [Related]
10. [Central thickness of the cornea in ocular hypertension and open-angle glaucoma].
Chiseliţă D; Danielescu C; Gagos-Zaharia O; Gherman C
Oftalmologia; 2007; 51(3):98-103. PubMed ID: 18064964
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
[TBL] [Abstract][Full Text] [Related]
12. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma.
Copt RP; Thomas R; Mermoud A
Arch Ophthalmol; 1999 Jan; 117(1):14-6. PubMed ID: 9930155
[TBL] [Abstract][Full Text] [Related]
13. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up.
Salvetat ML; Zeppieri M; Tosoni C; Brusini P;
Eye (Lond); 2016 Jun; 30(6):784-95. PubMed ID: 27174381
[TBL] [Abstract][Full Text] [Related]
14. Progression from ocular hypertension to visual field loss in the English hospital eye service.
Kelly SR; Khawaja AP; Bryan SR; Azuara-Blanco A; Sparrow JM; Crabb DP
Br J Ophthalmol; 2020 Oct; 104(10):1406-1411. PubMed ID: 32217541
[TBL] [Abstract][Full Text] [Related]
15. The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. A multicentre randomised controlled trial: baseline patient characteristics.
Konstantakopoulou E; Gazzard G; Vickerstaff V; Jiang Y; Nathwani N; Hunter R; Ambler G; Bunce C;
Br J Ophthalmol; 2018 May; 102(5):599-603. PubMed ID: 28982956
[TBL] [Abstract][Full Text] [Related]
16. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of corneal biomechanical properties with the Reichert Ocular Response Analyzer.
Detry-Morel M; Jamart J; Pourjavan S
Eur J Ophthalmol; 2011; 21(2):138-48. PubMed ID: 20853262
[TBL] [Abstract][Full Text] [Related]
18. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
[TBL] [Abstract][Full Text] [Related]
19. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
[TBL] [Abstract][Full Text] [Related]
20. Effect of prostaglandin analogues on the biomechanical corneal properties in patients with open-angle glaucoma and ocular hypertension measured with dynamic scheimpflug analyzer.
Martínez-Sánchez MI; Bolívar G; Sideroudi H; Teus MA
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3927-3933. PubMed ID: 35841397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
